captopril has been researched along with lisinopril in 209 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 19 (9.09) | 18.7374 |
| 1990's | 112 (53.59) | 18.2507 |
| 2000's | 49 (23.44) | 29.6817 |
| 2010's | 21 (10.05) | 24.3611 |
| 2020's | 8 (3.83) | 2.80 |
| Authors | Studies |
|---|---|
| Baum, T; Gold, EH; McNamara, P; Neustadt, BR; Smith, EM; Swiss, GF; Sybertz, EJ | 1 |
| Marshall, GR; Waller, CL | 1 |
| Chauvet, MT; Corvol, P; Michaud, A; Williams, TA | 1 |
| Abbenante, G; Fairlie, DP; Leung, D | 1 |
| Funakoshi, J; Kakumoto, M; Okumura, K; Sakaeda, T; Takara, K; Tanigawara, Y | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Agard, DA; Ashworth, A; Barrio-Hernandez, I; Batra, J; Beltrao, P; Bennett, MJ; Bohn, M; Bouhaddou, M; Braberg, H; Broadhurst, DJ; Cai, Y; Cakir, M; Calviello, L; Cavero, DA; Chang, JCJ; Chorba, JS; Craik, CS; d'Enfert, C; Dai, SA; Eckhardt, M; Emerman, M; Fabius, JM; Fletcher, SJ; Floor, SN; Foussard, H; Frankel, AD; Fraser, JS; Fujimori, DG; Ganesan, SJ; García-Sastre, A; Gordon, DE; Gross, JD; Guo, JZ; Haas, K; Haas, P; Hernandez-Armenta, C; Hiatt, J; Huang, XP; Hubert, M; Hüttenhain, R; Ideker, T; Jacobson, M; Jang, GM; Jura, N; Kaake, RM; Kim, M; Kirby, IT; Klippsten, S; Koh, C; Kortemme, T; Krogan, NJ; Kuzuoglu-Ozturk, D; Li, Q; Liboy-Lugo, J; Lin, Y; Liu, X; Liu, Y; Lou, K; Lyu, J; Mac Kain, A; Malik, HS; Mathy, CJP; McGregor, MJ; Melnyk, JE; Memon, D; Meyer, B; Miorin, L; Modak, M; Moreno, E; Mukherjee, S; Naing, ZZC; Noack, J; O'Meara, MJ; O'Neal, MC; Obernier, K; Ott, M; Peng, S; Perica, T; Pilla, KB; Polacco, BJ; Rakesh, R; Rathore, U; Rezelj, VV; Richards, AL; Roesch, F; Rosenberg, OS; Rosenthal, SB; Roth, BL; Roth, TL; Ruggero, D; Safari, M; Sali, A; Saltzberg, DJ; Savar, NS; Schwartz, O; Sharp, PP; Shen, W; Shengjuler, D; Shi, Y; Shoichet, BK; Shokat, KM; Soucheray, M; Stroud, RM; Subramanian, A; Swaney, DL; Taunton, J; Tran, QD; Trenker, R; Tummino, TA; Tutuncuoglu, B; Ugur, FS; Vallet, T; Venkataramanan, S; Verba, KA; Verdin, E; Vignuzzi, M; von Zastrow, M; Wang, HY; Wankowicz, SA; Wenzell, NA; White, KM; Xu, J; Young, JM; Zhang, Z; Zhou, Y | 1 |
| Codd, R; Gotsbacher, MP; Roth, L | 1 |
| He, Y; Hou, R; Hou, S; Liao, C; Xie, Z; Yan, G | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Auch-Schwelk, W; Bossaller, C; Claus, M; Fleck, E; Graf, K; Gräfe, M | 1 |
| McElligott, S; Perlroth, M; Raish, L | 1 |
| Diehl, KL; Wernze, H | 1 |
| Alhenc-Gelas, F; Clauser, E; Corvol, P; Wei, L | 1 |
| Mookherjee, S; Smulyan, H; Vardan, S | 1 |
| Manso, C; Mira, ML; Queirós, MJ; Silva, MM | 1 |
| Bost, JG; Leenders, PJ; Nelissen-Vrancken, MH; Smits, JF; Struijker-Boudier, HA | 1 |
| Brunner, HR; Hayoz, D; Meister, JJ; Perret, F; Tardy, Y; Waeber, B | 1 |
| Herman, AG | 1 |
| Sloman, G | 1 |
| Dietz, R; Nagel, F; Osterziel, KJ | 3 |
| Busch, C; Dietz, R; Karr, M; Osterziel, KJ | 1 |
| Dietz, R; Karr, M; Lemmer, B; Osterziel, KJ | 1 |
| Bach, R; Zardini, P | 1 |
| King, SJ; Oparil, S | 1 |
| Düsing, R; Hoffmann, G | 1 |
| Auch-Schwelk, W; Baumgarten, C; Bossaller, C; Fleck, E; Graf, K; Gräfe, M | 1 |
| De Mey, JG; Schiffers, PM; Struyker-Boudier, HA | 1 |
| Whelton, A | 1 |
| Brozovich, FV; Gottlieb, NB; Gottlieb, RS; Morganroth, J | 1 |
| Barnes, NM; Costall, B; Egli, P; Horovitz, ZP; Ironside, JW; Naylor, RJ; Williams, TJ | 1 |
| Rappelli, A | 1 |
| Graham, RD | 1 |
| Bennett, T; Gardiner, SM; Tomlinson, KC | 1 |
| Bönner, G; Kaufmann, W; Preis, S; Schunk, U; Toussaint, C | 1 |
| Danilov, S; Fanburg, BL; Lanzillo, JJ; Stevens, J | 1 |
| Mendelsohn, FA; Sun, Y | 1 |
| Franco-Saenz, R; Lotshaw, DP; Mulrow, PJ; Oda, H | 1 |
| Giles, TD | 3 |
| Braun, U; Brilla, GG; Heitkamp, HC; Klärner, HG; Krämer, BK; Müller-Schauenburg, W; Risler, T; Seipel, L | 1 |
| Ikram, H; White, HD | 1 |
| Franchi, F; Puddu, GM | 1 |
| Bönner, G; Düsing, R; Göbel, BO; Hoffmann, G; Pietsch, R; Vetter, H; Weisser, B | 1 |
| Ambrosioni, E; Malini, PL; Strocchi, E; Valtancoli, G | 1 |
| Ganten, D; Hellmann, T; Keuneke, C; Metzger, R; Peters, J; Yacullo, R | 1 |
| Bennett, T; Compton, AM; Gardiner, SM; Muller, AF | 1 |
| Amodeo, C | 1 |
| Lambert, M; Luccioni, R | 1 |
| Dunne, B; Hait, HI; Miller, WE; Tresznewsky, ON; Whelton, A | 1 |
| Chiaramida, A; DeMaria, AN; Giles, TD; Hackshaw, B; Hart, W; Haugland, M; Johnston, R; Katz, R; Kirlin, P; Powers, ER | 1 |
| Chiaramida, A; Giles, TD; Hackshaw, B; Haugland, M; Katz, R; Kirlin, P; Powers, E; Rich, S; Sullivan, JM; Wolfson, P | 1 |
| Jessup, M | 1 |
| Feinstein, AR; Fisher, MB; Pigeon, JG | 1 |
| Ino, Y; Iwaki, M; Iwamoto, S; Oda, M; Sato, T; Suzuki, K | 1 |
| Dallocchio, M; Gosse, P; Gourgon, R | 1 |
| Cushman, DW; DeForrest, JM; Fung, WC; Grover, GJ; Harvey, CM; Mitch, SL; Scalese, RJ; Wang, FL | 1 |
| Brunner, HR; Nussberger, J; Waeber, B | 1 |
| Frohlich, ED; Garavaglia, GE; Messerli, FH; Nunez, BD; Schmieder, RE | 1 |
| Fisher, MB; Giles, TD; Rush, JE | 1 |
| Bilezikian, JP; Cannon, PJ; Chow, YK; Corwin, SJ; Horn, EM; Neuberg, GW; Powers, ER; Steinberg, SF | 1 |
| Cumming, AM; Meredith, PA; Morton, JJ; Semple, PF | 1 |
| Bull, HG; Cordes, EH; Cordes, MH; Patchett, AA; Thornberry, NA | 1 |
| Biollaz, J; Brunner, DB; Brunner, HR; Desponds, G; Gomez, HJ; Hichens, M; Jacot Des Combes, B; Schelling, JL; Ulm, EH | 1 |
| Brunner, HR; Bussien, JP; Nussberger, J; Schaller, MD; Waeber, B | 1 |
| Cruickshank, HE | 1 |
| Franzosi, M; Latini, R; Maggioni, AP; Tognoni, G; Zuanetti, G | 1 |
| Wood, R | 1 |
| Barcina Sánchez, C; Fernández Fernández, A; Martín Cortés, M | 1 |
| Collins, TJ; Mehra, MR; Ramee, SR; Smart, FW; Stapleton, DD; Ventura, HO | 1 |
| Bauwens, LJ; Copper, MP; Schmidt, JT | 1 |
| Mann, S; O'Brien, KP | 1 |
| Díez, J; Laviades, C | 1 |
| Miselis, J; Siminiak, T; Wysocki, H | 1 |
| Manso, CF; Mira, ML; Silva, MM | 1 |
| Bayata, S; Postaci, N; Yeşil, M; Yeşil, S | 1 |
| Delage, Y; Gressin, V; Madonna, O; Poggi, L; Renucci, JF; Vaïsse, B | 1 |
| Malacco, E | 1 |
| Li Wan Po, A; Zhou, XH | 1 |
| Braun, N; Erley, CM; Komini, E; Nicaeus, T; Risler, T; Wolf, S | 2 |
| Mazzotta, G; Vecchio, C | 1 |
| Wang, JF; Xiao, WB | 1 |
| Manso, CF; Mira, ML; Queiroz, MJ; Silva, MM | 1 |
| Atienza Fernández, M; Carvajal Gragera, E; Piña Vera, MJ; Santos Ramos, B | 1 |
| Andrén, L; Hedner, T; Lindholm, L; Lötvall, J; Lunde, H; Samuelsson, O; Wiholm, BE | 1 |
| Alexander, S; Arbeit, L; Fadly, M; Hicks, R; Sorbi, D | 1 |
| Frable, MA; Thompson, T | 1 |
| Byttebier, G; Van Hedent, T; Van Mieghem, W | 1 |
| Bindlish, V; Jaber, LA; Melchior, WR | 1 |
| Aber, GM; Clayton, L; D'Souza, RJ; Davies, SJ; Hiley, C; Jones, PW; Strange, RC | 1 |
| Young, BA | 1 |
| Bumpus, FM; Husain, A; Kinoshita, A; Urata, H | 1 |
| Bagatin, J; Janezić, A; Marinković, M; Rumboldt, M; Rumboldt, Z; Simunić, M | 1 |
| Coulter, DM; Pillans, PI | 1 |
| Amici, D; Bramucci, M; Canofeni, S; Maccari, E; Miano, A; Quassinti, L | 1 |
| Gill, TH; Hauter, F; Pelter, MA | 1 |
| Caines, VV; Gerrets, RP; Hendricks-Munoz, KD; Higgins, RD; Munoz, JL | 1 |
| Black, P; Coulter, DM; Pillans, PI | 1 |
| Jespersen, TW; Larsen, JK; Nielsen, MB | 1 |
| Giles, TD; Quiroz, A; Roffidal, L; Sander, G; Tresznewsky, O | 1 |
| Amadi, A; Coats, A; Gibson, DG; Henein, MY; O'Sullivan, C | 1 |
| Anderssson, PE; Berglund, L; Haenni, A; Lind, L; Lithell, H; Reneland, R | 1 |
| de Cavanagh, EM; Ferder, L; Fraga, CG; Inserra, F | 1 |
| Argenziano, L; Condorelli, M; Crepaldi, G; Morisco, C; Rizzon, P; Trimarco, B; Villa, G; Zardini, P | 1 |
| Maier, H; Tisch, M | 1 |
| Morris, SD; Yellon, DM | 1 |
| Mori, A; Noda, Y; Packer, L | 1 |
| Gao, XP; Olopade, CO; Pakhlevaniants, S; Rubinstein, I; Suzuki, H | 1 |
| O'Valle, F; Pérez-Caballero, C; Rodríguez-Puyol, D; Rodríguez-Puyol, M; Ruiz-Ginés, JA | 1 |
| Chisi, JE; Riches, AC; Wdzieczak-Bakala, J | 1 |
| Rao, NM; Udupa, EG | 2 |
| Amici, D; Bramucci, M; Gobbetti, A; Maccari, E; Miano, A; Murri, O; Quassinti, L; Zerani, M | 1 |
| Kandaswamy, V; Sen, S; Yang, CM; Young, D | 1 |
| Cia, P; del Arco, C; Fernandez, C; Fernández, F; Garcia, I; Gill, B; Gonzalez, L; Luque, M; Maldonado, A; Marin, R; Martell, N; Suarez, C; Tovar, JL; Yuste, I | 1 |
| Krishan, P; Sharma, A; Singh, M | 1 |
| Anning, PB; Grocott-Mason, RM; Lewis, MJ | 1 |
| Hamlin, R; Mandigers, PJ; Pijpers, FS | 1 |
| Constantinescu, CS; Goodman, DB; Ventura, ES | 1 |
| D'Alessio, O; Falcone, G; Giassa, T; Mangrella, M; Mazzeo, F; Motola, G; Rossi, F; Russo, F | 1 |
| Rady, MY; Ryan, T | 1 |
| Channer, K; O'Toole, L; Padfield, P; Stewart, M | 1 |
| Amici, D; Bramucci, M; Maccari, E; Miano, A; Murri, O; Quassinti, L | 2 |
| Akarawut, W; Lin, CJ; Smith, DE | 1 |
| Lee, AF; MacFadyen, RJ; Morton, JJ; Pringle, SD; Struthers, AD | 1 |
| Coates, D; Ekbote, U; Isaac, RE | 1 |
| Binevski, PV; Gomazkov, OA; Grinshtein, SV; Kost, OA; Nikolskaya, II; Pozdnev, VF | 1 |
| Kim, YT; Molteni, A; Small, W; Taylor, JM; Ts'ao, CH; Ward, WF | 1 |
| Katayama, H; Matsuse, T; Ohga, E; Ouchi, Y; Suzuki, M; Teramoto, S | 1 |
| Fitilev, SB; Ol'binskaia, LI; Potapova, GN; Pukhlianko, ME; Sergeeva, TE; Sizova, ZhM; Zheleznykh, EA | 1 |
| Cruz, CI; del Moral, RG; Rodríguez-Puyol, D; Rodríguez-Puyol, M; Ruiz-Torres, P | 1 |
| Berger, R; Frey, B; Kozanly, I; Kuchling, G; Pacher, R; Stanek, B | 1 |
| Ishii, T; Matsuse, T; Ohga, E; Ouchi, Y; Suzuki, M; Teramoto, S | 1 |
| Fagard, R; Lijnen, P; Petrov, V | 1 |
| Buikema, H; Crijns, HJ; de Zeeuw, D; Monnink, SH; Tio, RA; van Gilst, WH | 1 |
| Fernandez, M; Heyberger, S; Husain, A; Liu, X; Wouters, MA | 1 |
| Chen, YT; Krumholz, HM; Radford, MJ; Wang, Y | 1 |
| Agarwal, A; Anuradha, S; Rizvi, SN; Singh, NP; Uppal, M | 1 |
| Borhani, M; Curci, JA; Kelley, BJ; Liao, S; Miralles, M; Thompson, RW | 1 |
| Binevski, PV; Garats, EV; Kost, OA; Nikolskaya, II; Pozdnev, VF | 1 |
| Ball, BA; Sabeur, K; Vo, AT | 1 |
| Bartra, J; Bonet, A; Gaig, P; García-Ortega, P; San Miguel-Moncin, MM | 1 |
| Remme, WJ | 1 |
| Nagappa, AN; Pandi, V; Patil, RT; Ziauddin, K | 1 |
| Bicket, DP | 1 |
| Erinola, M; Tepel, M; van der Giet, M; Zidek, W | 1 |
| Ambrosioni, E; Borghi, C | 1 |
| Kim, HM; Lee, H; Lee, JO; Shin, DR; Yoo, OJ | 1 |
| Ekbote, U; Isaac, RE; Looker, M | 1 |
| Jacobsen, P; Parving, HH; Pietraszek, L; Rossing, K | 1 |
| Buikema, H; de Zeeuw, D; Gschwend, S; Henning, RH; Pinto, YM; van Gilst, WH | 1 |
| Binevski, PV; Kost, OA; Pozdnev, VF; Sizova, EA | 1 |
| Gao, L; Kern, TS; Widness, M; Xi, X; Zhang, JZ | 1 |
| Kvan, E; Reikvam, A | 1 |
| Keltai, M | 1 |
| Iakubov, AV; Usmanova, ShE | 1 |
| Andújar-Sánchez, M; Cámara-Artigas, A; Jara-Pérez, V | 1 |
| Alican, I; Ercan, F; Gedik, N; Jahovic, N; Sener, G; Yüksel, M | 1 |
| Binevski, PV; Kost, OA; Pozdnev, VF; Skirgello, OE | 1 |
| Cohen-Solal, A; Dietz, R; Eichhorn, E; Erhardt, L; Hobbs, FD; Krum, H; Maggioni, A; McKelvie, RS; McMurray, J; Piña, IL; Soler-Soler, J; Swedberg, K | 1 |
| Kuster, DJ; Marshall, GR | 1 |
| Buikema, H; Schoemaker, RG; van Gilst, WH; van Veldhuisen, DJ; Westendorp, B | 1 |
| Dem'iankova, IuO; Kratnov, AA; Kratnov, AE; Popov, SA | 1 |
| Babar, S; Ducobu, J; Legssyer, I; Moguilevsky, N; Moreau, P; Nève, J; Van Antwerpen, P; Vanhaeverbeek, M; Zouaoui Boudjeltia, K | 1 |
| Araki, H; Fujiwara, M; Nishi, K; Ohkubo, I; Sakaue, T; Takeuchi, K; Yamamoto, Y | 1 |
| Dilsizian, V; Eckelman, WC; Narula, J; Narula, N; Shirani, J | 1 |
| Brower, GL; Janicki, JS; Levick, SP | 1 |
| Apostolakis, S; Baritaki, S; Kochiadakis, GE; Krambovitis, E; Spandidos, DA; Vlata, Z | 1 |
| Brecher, AS; Dubord, R | 1 |
| Brecher, AS; Gray, KD; Murrey, SJ; Poulimenos, JN | 1 |
| Chung, JS; Webster, SG | 1 |
| Celiński, K; Czechowska, G; Korobowicz, E; Korolczuk, A; Madro, A; Prozorow-Król, B; Słomka, M | 1 |
| Haverkos, HW | 1 |
| Harty, DWS; Hunter, N | 1 |
| Chou, J; Debanne, SM; Fang, JC; Mishra, P; Simon, DI; Sipahi, I | 1 |
| Cohen, EP; Gore, E; Kharofa, J; Tomic, R; Xiang, Q | 1 |
| Bush, ED; Fabian, E; Herold, M; Kamp, HG; Krennrich, G; Looser, R; Mattes, WB; Mellert, W; Moeller, N; Nadanaciva, S; Naraoka, H; Omura, K; Piccoli, SP; Prokoudine, A; Ruiz-Noppinger, P; Schuppe-Koistinen, I; Strauss, V; van Ravenzwaay, B; Walk, T | 1 |
| Altschuh, D; Cakir-Kiefer, C; Corbier, C; Girardet, JM; Miclo, L; Zeder-Lutz, G; Zidane, F | 1 |
| Helal, F; Lane, ME | 1 |
| Cohen, EP; Fish, BL; Moulder, JE | 1 |
| Antonio, RC; Gerlach, RF; Izidoro-Toledo, TC; Kuntze, LB; Meschiari, CA; Tanus-Santos, JE | 1 |
| Shen, S; Shi, Y; Yang, X | 1 |
| Cass, QB; de Almeida, FG; Vanzolini, KL | 1 |
| Naveed, S; Qamar, F; Sana, A; Shakeel, S | 1 |
| Ambrosioni, E; Bacchelli, S; Borghi, C; Esposti, DD; Omboni, S; Reggiardo, G | 1 |
| Barnett, SA; Castelletto, V; Hamley, IW; Ruokolainen, J; Sandu, C; Seitsonen, J | 1 |
| Karahan, F; Turkoglu, V | 1 |
| Ahmad, HA; Al Farabi, MJ; Azmi, Y; Gandi, P; Givani, CL; Lumeno, ISP; Oktaviono, YH | 1 |
| Carpenter, A; Dale-Harris, I; Dorée, C; Estcourt, LJ; Roy, NB | 1 |
22 review(s) available for captopril and lisinopril
| Article | Year |
|---|---|
Protease inhibitors: current status and future prospects.
Topics: Animals; Aspartic Acid Endopeptidases; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Humans; Metalloendopeptidases; Models, Molecular; Protease Inhibitors; Serine Endopeptidases; Serine Proteinase Inhibitors | 2000 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Zinc enzymes in medicinal chemistry.
Topics: Chemistry, Pharmaceutical; Enzyme Inhibitors; Enzymes; Humans; Models, Molecular; Zinc | 2021 |
Differences in structure of angiotensin-converting enzyme inhibitors might predict differences in action.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Dipeptides; Humans; Lisinopril | 1992 |
Angiotensin-converting enzyme inhibition, the sympathetic nervous system, and congestive heart failure. The Australian Zestril (Lisinopril) Study Group.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Catecholamines; Dipeptides; Heart Failure; Humans; Lisinopril; Sympathetic Nervous System | 1992 |
Comparison of lisinopril and captopril in the treatment of left ventricular congestive heart failure--influence of duration of action on efficacy and safety.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Drug Administration Schedule; Enalapril; Heart Failure; Hemodynamics; Humans; Kidney Function Tests; Lisinopril; Ventricular Function, Left | 1991 |
[ACE inhibitors and heart failure].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Heart Failure; Humans; Isoquinolines; Lisinopril; Quinapril; Tetrahydroisoquinolines | 1990 |
Lisinopril in the treatment of congestive heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Double-Blind Method; Enalapril; Heart Failure; Humans; Lisinopril; Random Allocation | 1989 |
The present molecules of converting enzyme inhibitors.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Blood Pressure; Bridged Bicyclo Compounds; Captopril; Cilazapril; Cyclopentanes; Dipeptides; Enalapril; Humans; Indoles; Lisinopril; Perindopril; Pyridazines; Ramipril; Renin-Angiotensin System | 1985 |
ACE inhibitors--the trickle becomes a flood.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Humans; Lisinopril | 1988 |
[Lisinopril in the treatment of heart insufficiency].
Topics: Captopril; Clinical Trials as Topic; Digoxin; Enalapril; Exercise Test; Heart Failure; Hemodynamics; Humans; Lisinopril; Quality of Life | 1995 |
Optimizing the treatment of heart failure.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Calcium Channel Blockers; Captopril; Clinical Trials as Topic; Contraindications; Digitalis; Digoxin; Diuretics; Enalapril; Heart Failure; Humans; Hydralazine; Lisinopril; Nitrates; Plants, Medicinal; Plants, Toxic; Randomized Controlled Trials as Topic; Stroke Volume | 1994 |
[Angiotensin converting enzyme inhibitors during acute phase of myocardial infarct].
Topics: Administration, Oral; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Enalapril; Female; Humans; Injections, Intravenous; Lisinopril; Male; Multicenter Studies as Topic; Myocardial Infarction; Nitroglycerin; Ramipril; Thrombolytic Therapy; Time Factors | 1994 |
Angiotensin-converting enzyme inhibitors in diabetic nephropathy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Capillary Resistance; Captopril; Diabetic Nephropathies; Dipeptides; Enalapril; Humans; Hyperglycemia; Lisinopril | 1993 |
Angiooedema and urticaria with angiotensin converting enzyme inhibitors.
Topics: Adverse Drug Reaction Reporting Systems; Angioedema; Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Drug Monitoring; Enalapril; Humans; Lisinopril; Urticaria | 1996 |
Using ACE inhibitors appropriately.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Captopril; Cardiovascular Diseases; Clinical Trials as Topic; Contraindications; Diabetic Nephropathies; Drug Costs; Enalapril; Fosinopril; Heart Failure; Humans; Hypertension; Indoles; Isoquinolines; Lisinopril; Meta-Analysis as Topic; Myocardial Infarction; Perindopril; Quinapril; Ramipril; Renin-Angiotensin System; Risk; Tetrahydroisoquinolines; United States | 2002 |
[Preventive therapy with ACE inhibitors for coronary patients].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Clinical Trials as Topic; Coronary Disease; Death, Sudden, Cardiac; Enalapril; Humans; Indoles; Lisinopril; Myocardial Infarction; Perindopril; Ramipril; Treatment Outcome | 2004 |
Early imaging in heart failure: exploring novel molecular targets.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Captopril; Fluorine Radioisotopes; Heart Failure; Humans; Imidazoles; Lisinopril; Positron-Emission Tomography; Pyridines; Radiopharmaceuticals; Renin-Angiotensin System; Ventricular Remodeling | 2007 |
Meta-analysis of randomized controlled trials on effect of angiotensin-converting enzyme inhibitors on cancer risk.
Topics: Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Captopril; Enalapril; Fosinopril; Humans; Lisinopril; Neoplasms; Quinapril; Ramipril; Randomized Controlled Trials as Topic; Tetrahydroisoquinolines | 2011 |
Transdermal delivery of Angiotensin Converting Enzyme inhibitors.
Topics: Administration, Cutaneous; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiovascular Diseases; Diabetic Nephropathies; Enalapril; Heart Failure; Humans; Hypertension; Indoles; Lisinopril; Perindopril; Skin | 2014 |
Effects of the concomitant administration of xanthine oxidase inhibitors with zofenopril or other ACE-inhibitors in post-myocardial infarction patients: a meta-analysis of individual data of four randomized, double-blind, prospective studies.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Double-Blind Method; Enzyme Inhibitors; Female; Humans; Lisinopril; Male; Middle Aged; Myocardial Infarction; Progression-Free Survival; Prospective Studies; Ramipril; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome; Xanthine Oxidase | 2018 |
Interventions for chronic kidney disease in people with sickle cell disease.
Topics: Acute Chest Syndrome; Adolescent; Adult; Anemia, Sickle Cell; Angiotensin-Converting Enzyme Inhibitors; Antisickling Agents; Ascorbic Acid; Captopril; Child; Creatinine; Humans; Hydroxyurea; Kidney Failure, Chronic; Lisinopril; Proteinuria | 2023 |
35 trial(s) available for captopril and lisinopril
| Article | Year |
|---|---|
Non-invasive determination of arterial diameter and distensibility by echo-tracking techniques in hypertension.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Animals; Arteries; Atenolol; Blood Pressure; Captopril; Compliance; Dipeptides; Double-Blind Method; Humans; Hydralazine; Hypertension; Lisinopril; Nitrendipine; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Ultrasonography | 1992 |
Effect of captopril and lisinopril on circadian blood pressure rhythm and renal function in mild-to-moderate heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Cardiac Output, Low; Circadian Rhythm; Creatinine; Dipeptides; Female; Heart Failure; Heart Rate; Humans; Kidney; Lisinopril; Male; Middle Aged; Potassium; Renin | 1992 |
Long-acting angiotensin-converting enzyme inhibition: once-daily lisinopril versus twice-daily captopril in mild-to-moderate heart failure.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Arrhythmias, Cardiac; Captopril; Cardiac Output, Low; Creatinine; Digitalis Glycosides; Dipeptides; Diuretics; Double-Blind Method; Drug Administration Schedule; Electrocardiography, Ambulatory; Exercise Test; Female; Heart Failure; Humans; Lisinopril; Male; Middle Aged; Placebos; Potassium; Urea | 1992 |
Application of ambulatory blood pressure monitoring to clinical therapeutic decisions in hypertension.
Topics: Antihypertensive Agents; Blood Pressure; Blood Pressure Determination; Blood Pressure Monitors; Captopril; Circadian Rhythm; Double-Blind Method; Enalapril; Female; Humans; Hypertension; Lisinopril; Male; Middle Aged; Prospective Studies | 1991 |
Controlling hypertension: lisinopril-hydrochlorothiazide vs captopril-hydrochlorothiazide. An Italian multicentre study.
Topics: Adolescent; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Drug Combinations; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Italy; Lisinopril; Male; Middle Aged | 1991 |
Treating mild-to-moderate hypertension: a comparison of lisinopril-hydrochlorothiazide fixed combination with captopril and hydrochlorothiazide free combination.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Lisinopril; Male; Middle Aged | 1991 |
[Changes in kidney function during treatment of heart failure patients with ACE inhibitors].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Heart Failure; Hemodynamics; Humans; Kidney Function Tests; Lisinopril | 1991 |
[Comparison of lisinopril and captopril in treatment of severe heart failure (NYHA III-IV) in high risk patients. Preliminary results of the trial].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiomyopathy, Dilated; Coronary Disease; Enalapril; Female; Heart Failure; Hemodynamics; Humans; Kidney Function Tests; Lisinopril; Male; Middle Aged | 1991 |
ACE inhibition and pressor responsiveness to norepinephrine in hypertensive patients.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Drug Administration Schedule; Enalapril; Female; Humans; Hypertension; Lisinopril; Male; Middle Aged; Norepinephrine; Random Allocation | 1990 |
Once-daily lisinopril compared with twice-daily captopril in the treatment of mild to moderate hypertension: assessment of office and ambulatory blood pressures.
Topics: Ambulatory Care; Blood Pressure; Blood Pressure Determination; Captopril; Diastole; Double-Blind Method; Drug Administration Schedule; Enalapril; Heart Rate; Humans; Hypertension; Lisinopril; Research Design; Single-Blind Method; Systole | 1990 |
A double-blind comparison of lisinopril with captopril in patients with symptomatic congestive heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Double-Blind Method; Enalapril; Female; Heart Failure; Heart Function Tests; Humans; Lisinopril; Male; Middle Aged; Physical Exertion; Random Allocation | 1987 |
Short- and long-acting angiotensin-converting enzyme inhibitors: a randomized trial of lisinopril versus captopril in the treatment of congestive heart failure. The Multicenter Lisinopril-Captopril Congestive Heart Failure Study Group.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Double-Blind Method; Enalapril; Female; Heart Failure; Humans; Lisinopril; Male; Middle Aged; Multicenter Studies as Topic; Random Allocation | 1989 |
ACE inhibitors in mild to moderate hypertension: comparison of lisinopril and captopril administered once daily. French Cooperative Study Group.
Topics: Adolescent; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Lisinopril; Male; Middle Aged; Multicenter Studies as Topic; Random Allocation | 1989 |
Lisinopril in the treatment of congestive heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Double-Blind Method; Enalapril; Heart Failure; Humans; Lisinopril; Random Allocation | 1989 |
Lisinopril and captopril in the treatment of heart failure in older patients. Comparison of a long- and short-acting angiotensin-converting enzyme inhibitor.
Topics: Age Factors; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Double-Blind Method; Enalapril; Exercise Test; Female; Heart Failure; Humans; Lisinopril; Male; Random Allocation; Stroke Volume; Time Factors | 1988 |
[Therapy with ACE inhibitors in chronic heart failure and limited kidney function].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Blood Flow Velocity; Blood Pressure; Captopril; Creatinine; Drug Therapy, Combination; Enalapril; Female; Glomerular Filtration Rate; Heart Failure; Humans; Kidney Failure, Chronic; Kidney Function Tests; Lisinopril; Male; Middle Aged; Renal Circulation | 1994 |
Once daily lisinopril and captopril in hypertension: a double blind comparison using ambulatory monitoring.
Topics: Adult; Aged; Blood Pressure Monitoring, Ambulatory; Captopril; Cross-Over Studies; Double-Blind Method; Drug Monitoring; Female; Humans; Hypertension; Lisinopril; Male; Middle Aged; Time Factors | 1994 |
Insulin-like growth factor-1 and cardiac mass in essential hypertension: comparative effects of captopril, lisinopril and quinapril.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Captopril; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Insulin-Like Growth Factor I; Isoquinolines; Lisinopril; Male; Middle Aged; Myocardium; Quinapril; Tetrahydroisoquinolines | 1994 |
[Evaluation of the antihypertensive efficacy of lisinopril and captopril associated with hydrochlorothiazide by ambulatory measurement of arterial pressure].
Topics: Adult; Ambulatory Care; Antihypertensive Agents; Blood Pressure Determination; Captopril; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Lisinopril; Male; Middle Aged | 1993 |
Combination therapy versus monotherapy in hypertensive patients: an Italian multicentre study.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Captopril; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Italy; Lisinopril; Male; Middle Aged; Nitrendipine | 1993 |
Reduction of proteinuria and changes of renal function in patients with glomerulonephritis and mild renal insufficiency. Short- versus long-acting angiotensin-converting enzyme inhibitors.
Topics: Adult; Basement Membrane; Captopril; Double-Blind Method; Female; Glomerulonephritis; Humans; Hypertension, Renal; Kidney Failure, Chronic; Kidney Glomerulus; Lisinopril; Male; Middle Aged; Prospective Studies; Proteinuria; Renal Circulation | 1994 |
[The effect of angiotensin-converting enzyme inhibitors on proteinuria in chronic glomerulonephritis].
Topics: Adult; Aged; Captopril; Chronic Disease; Double-Blind Method; Female; Glomerulonephritis; Humans; Lisinopril; Male; Middle Aged; Proteinuria | 1994 |
Acute haemodynamic effects of lisinopril and captopril in patients with severe congestive heart failure.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Dipeptides; Female; Heart Failure; Hemodynamics; Humans; Lisinopril; Male; Middle Aged | 1993 |
Randomised, double-blind crossover comparison of once-daily captopril and lisinopril in patients with mild to moderate hypertension--a community-based study. Hunter Hypertension Research Group.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Captopril; Dipeptides; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hypertension; Lisinopril; Male; Middle Aged; Patient Compliance; Therapeutic Equivalency | 1993 |
Controlled multicentre comparison of captopril versus lisinopril in the treatment of mild-to-moderate arterial hypertension.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Body Weight; Captopril; Creatinine; Dipeptides; Electrocardiography; Female; Heart Rate; Humans; Hypertension; Lisinopril; Male; Middle Aged | 1993 |
Conversions from captopril to lisinopril at a dosage ratio of 5:1 result in comparable control of hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Drug Costs; Female; Humans; Hypertension; Lisinopril; Male; Middle Aged; Prospective Studies; Retrospective Studies; Treatment Outcome | 1996 |
Circadian variation in blood pressure and heart rate in nonhypertensive congestive heart failure.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Captopril; Circadian Rhythm; Digoxin; Diuretics; Double-Blind Method; Female; Heart Failure; Heart Rate; Humans; Lisinopril; Male; Middle Aged; Norepinephrine | 1996 |
The alterations in insulin sensitivity during angiotensin converting enzyme inhibitor treatment are related to changes in the calcium/magnesium balance.
Topics: Adolescent; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium; Captopril; Double-Blind Method; Enalapril; Female; Fosinopril; Humans; Hypertension; Insulin; Lisinopril; Magnesium; Male; Middle Aged | 1997 |
Lisinopril in the treatment of congestive heart failure in elderly patients: comparison versus captopril.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Double-Blind Method; Echocardiography; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Lisinopril; Male; Middle Aged; Quality of Life; Stroke Volume | 1997 |
Trough to peak ratio of once-daily lisinopril and twice-daily captopril in patients with essential hypertension.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Drug Administration Schedule; Female; Humans; Hypertension; Lisinopril; Male; Middle Aged | 1998 |
Effect of the insertion/deletion polymorphism of the angiotensin-converting enzyme gene on response to angiotensin-converting enzyme inhibitors in patients with heart failure.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Cross-Over Studies; Female; Gene Deletion; Glomerular Filtration Rate; Heart Failure; Humans; Kidney; Lisinopril; Male; Middle Aged; Mutagenesis, Insertional; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Pressoreceptors; Prospective Studies; Single-Blind Method; Treatment Outcome | 1998 |
[Antihypertensive efficacy, tolerance and safety of lisinopril (sinopril) and captopril (capoten) in patients with mild and moderate arterial hypertension].
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Diuretics; Drug Hypersensitivity; Drug Therapy, Combination; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Lisinopril; Male; Safety; Severity of Illness Index; Sodium Chloride Symporter Inhibitors; Treatment Outcome | 1999 |
Double-blind comparison between zofenopril and lisinopril in patients with acute myocardial infarction: results of the Survival of Myocardial Infarction Long-term Evaluation-2 (SMILE-2) study.
Topics: Adolescent; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Double-Blind Method; Drug Therapy, Combination; Female; Fibrinolytic Agents; Humans; Hypotension; Lisinopril; Male; Middle Aged; Myocardial Infarction; Recurrence; Survival Rate | 2003 |
Renoprotective effects of adding angiotensin II receptor blocker to maximal recommended doses of ACE inhibitor in diabetic nephropathy: a randomized double-blind crossover trial.
Topics: Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Captopril; Cross-Over Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Drug Therapy, Combination; Enalapril; Female; Humans; Kidney; Lisinopril; Male; Middle Aged; Tetrazoles; Treatment Outcome | 2003 |
[Lisinopril-induced changes in antioxidant defense in patients with acute coronary syndrome and concomitant diabetes mellitus type 2].
Topics: Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Captopril; Catalase; Diabetes Mellitus, Type 2; Disease Progression; Female; Follow-Up Studies; Glutathione Reductase; Humans; Lisinopril; Male; Middle Aged; Myocardial Ischemia; Neutrophils; Oxidative Stress; Oxidoreductases; Peroxidase; Severity of Illness Index; Spectrophotometry; Superoxide Dismutase; Treatment Outcome | 2005 |
153 other study(ies) available for captopril and lisinopril
| Article | Year |
|---|---|
Angiotensin converting enzyme inhibitors: spirapril and related compounds.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Chemical Phenomena; Chemistry; Dogs; Enalapril; Male; Phenylbutyrates; Rats; Rats, Inbred Strains; Spiro Compounds | 1989 |
Three-dimensional quantitative structure-activity relationship of angiotesin-converting enzyme and thermolysin inhibitors. II. A comparison of CoMFA models incorporating molecular orbital fields and desolvation free energies based on active-analog and com
Topics: Angiotensin-Converting Enzyme Inhibitors; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Thermolysin | 1993 |
Substrate dependence of angiotensin I-converting enzyme inhibition: captopril displays a partial selectivity for inhibition of N-acetyl-seryl-aspartyl-lysyl-proline hydrolysis compared with that of angiotensin I.
Topics: Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Binding Sites; Captopril; Chlorides; CHO Cells; Cricetinae; Hydrogen-Ion Concentration; Hydrolysis; Kinetics; Oligopeptides; Peptidyl-Dipeptidase A; Protein Structure, Tertiary; Substrate Specificity | 1997 |
Interaction of digoxin with antihypertensive drugs via MDR1.
Topics: Animals; Antihypertensive Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cells, Cultured; Digoxin; Drug Interactions; Humans; Time Factors | 2002 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.
Topics: Animals; Antiviral Agents; Betacoronavirus; Chlorocebus aethiops; Cloning, Molecular; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Evaluation, Preclinical; Drug Repositioning; HEK293 Cells; Host-Pathogen Interactions; Humans; Immunity, Innate; Mass Spectrometry; Molecular Targeted Therapy; Pandemics; Pneumonia, Viral; Protein Binding; Protein Biosynthesis; Protein Domains; Protein Interaction Mapping; Protein Interaction Maps; Receptors, sigma; SARS-CoV-2; SKP Cullin F-Box Protein Ligases; Vero Cells; Viral Proteins | 2020 |
Immobilized Metal Affinity Chromatography as a Drug Discovery Platform for Metalloenzyme Inhibitors.
Topics: Chromatography, Affinity; Coordination Complexes; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Discovery; Humans; Imino Acids; Metalloproteins; Metals, Heavy; Models, Molecular; Molecular Structure; Structure-Activity Relationship | 2020 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Local potentiation of bradykinin-induced vasodilation by converting-enzyme inhibition in isolated coronary arteries.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Bradykinin; Captopril; Cattle; Coronary Vessels; Dipeptides; Enalaprilat; Endothelium, Vascular; Fosinopril; Humans; In Vitro Techniques; Lisinopril; Muscle Relaxation; Muscle, Smooth, Vascular; Nitroarginine; Ramipril; Receptors, Bradykinin; Receptors, Neurotransmitter; Vasodilation; Vasodilator Agents | 1992 |
Angioedema after substituting lisinopril for captopril.
Topics: Adult; Angioedema; Angiotensin-Converting Enzyme Inhibitors; Captopril; Drug Hypersensitivity; Enalapril; Humans; Lisinopril; Male | 1992 |
[Angioneurotic edema caused by angiotensin-converting enzyme inhibitors].
Topics: Angioedema; Angiotensin-Converting Enzyme Inhibitors; Captopril; Complement C1 Inactivator Proteins; Enalapril; Epinephrine; Glucocorticoids; Histamine Antagonists; Humans; Lisinopril; Time Factors | 1992 |
The two homologous domains of human angiotensin I-converting enzyme interact differently with competitive inhibitors.
Topics: Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Binding Sites; Captopril; Chlorides; CHO Cells; Cricetinae; Enalapril; Enalaprilat; Humans; Indoles; Kinetics; Lisinopril; Mutation; Peptidyl-Dipeptidase A | 1992 |
Captopril administered every three hours in difficult-to-control hypertension.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Drug Administration Schedule; Enalapril; Humans; Hypertension, Renovascular; Lisinopril; Male | 1992 |
[Angiotensin-converting enzyme inhibitors as neutralizers of hydroxyl radical].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Dipeptides; Edetic Acid; Enalapril; Free Radical Scavengers; Hydroxides; Hydroxyl Radical; Lisinopril | 1992 |
Comparison of angiotensin-converting enzyme inhibitors in the rat in perfused hindlimbs and in vivo.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Dipeptides; Dose-Response Relationship, Drug; Hemodynamics; Hindlimb; Lisinopril; Male; Peptidyl-Dipeptidase A; Perfusion; Rats; Rats, Inbred SHR; Vascular Resistance | 1992 |
Angiotensin-converting enzyme inhibitors and renal function in heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Aspirin; Blood Pressure; Captopril; Dipeptides; Female; Glomerular Filtration Rate; Heart Failure; Heart Rate; Humans; Inulin; Kidney; Lisinopril; Male; Middle Aged; p-Aminohippuric Acid; Renal Circulation; Retrospective Studies | 1992 |
Comparison of the first-dose effect of captopril and lisinopril in heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Cardiac Output, Low; Circadian Rhythm; Dipeptides; Female; Heart Failure; Heart Rate; Humans; Lisinopril; Male; Middle Aged | 1992 |
Converting-enzyme inhibitors increase converting-enzyme mRNA and activity in endothelial cells.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cells, Cultured; Dipeptides; Dose-Response Relationship, Drug; Endothelium, Vascular; Gene Expression; Lisinopril; Peptidyl-Dipeptidase A; RNA, Messenger; Swine; Time Factors; Transcription, Genetic | 1992 |
ACE-inhibition, kinins, and vascular PGI2 synthesis.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Blood Platelets; Captopril; Cyclic AMP; Cyclic GMP; Dipeptides; Epoprostenol; Female; Humans; Kallikreins; Kinins; Lisinopril; Male; Muscle, Smooth, Vascular; Ramipril; Rats; Rats, Sprague-Dawley | 1992 |
Effects of converting enzyme inhibition on endothelial bradykinin metabolism and endothelium-dependent vascular relaxation.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Captopril; Cattle; Cells, Cultured; Coronary Vessels; Dipeptides; Enalaprilat; Endothelium, Vascular; Humans; In Vitro Techniques; Isometric Contraction; Kinetics; Lisinopril; Vasodilation | 1992 |
Effects of angiotensin II and angiotensin converting enzyme inhibitors on contractile and growth responses in isolated carotid arteries of the rat.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Carotid Arteries; DNA; Enalapril; In Vitro Techniques; Lisinopril; Male; Rats; Rats, Inbred WKY; Vasoconstriction | 1991 |
Effect of angiotensin converting enzyme inhibition on the incidence of restenosis after percutaneous transluminal coronary angioplasty.
Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inhibitors; Captopril; Combined Modality Therapy; Coronary Disease; Enalapril; Female; Follow-Up Studies; Heart Failure; Humans; Hypertension; Lisinopril; Male; Middle Aged; Recurrence | 1991 |
Characterisation of [3H]ceranapril recognition sites in rat and human brain tissue.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Animals; Binding Sites; Brain; Captopril; Enalapril; Female; Fosinopril; Humans; Kinetics; Lisinopril; Male; Middle Aged; Organophosphorus Compounds; Proline; Rats; Thiorphan | 1991 |
Hypotensive effects of angiotensin II analogues and angiotensin converting enzyme inhibitors in water-deprived Brattleboro rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Body Weight; Captopril; Enalapril; Heart Rate; Lisinopril; Male; Rats; Rats, Brattleboro; Saralasin; Water Deprivation | 1990 |
Hemodynamic effects of bradykinin on systemic and pulmonary circulation in healthy and hypertensive humans.
Topics: Adult; Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Bradykinin; Captopril; Cardiac Output; Enalapril; Female; Heart Rate; Hemodynamics; Humans; Hypertension; Lisinopril; Male; Middle Aged; Pulmonary Circulation; Vascular Resistance | 1990 |
A sensitive two-site sandwich enzyme immunoassay for human angiotensin converting enzyme utilizing monoclonal antibodies.
Topics: Animals; Antibodies, Monoclonal; Captopril; Cattle; Cross Reactions; Dose-Response Relationship, Immunologic; Enalapril; Epitopes; Humans; Immunoenzyme Techniques; Lisinopril; Peptidyl-Dipeptidase A; Protein Denaturation | 1990 |
Angiotensin converting enzyme inhibition in heart, kidney, and serum studied ex vivo after administration of zofenopril, captopril, and lisinopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Autoradiography; Captopril; Enalapril; Iodine Radioisotopes; Kidney; Lisinopril; Male; Myocardium; Oxidation-Reduction; Peptidyl-Dipeptidase A; Rats; Rats, Inbred Strains | 1991 |
Local generation of angiotensin II as a mechanism of aldosterone secretion in rat adrenal capsules.
Topics: Adrenal Glands; Aldosterone; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Enalapril; Female; In Vitro Techniques; Lisinopril; Peptidyl-Dipeptidase A; Rats; Rats, Inbred Strains | 1991 |
Long- versus short-acting angiotensin-converting enzyme inhibitors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Heart Failure; Humans; Lisinopril | 1990 |
Converting enzyme inhibition and vascular prostacyclin synthesis: effect of kinin receptor antagonism.
Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Captopril; Eicosanoids; Enalapril; Epoprostenol; Female; In Vitro Techniques; Lisinopril; Muscle, Smooth; Rats; Rats, Inbred Strains; Receptors, Bradykinin; Receptors, Neurotransmitter | 1990 |
The role of tissue renin-angiotensin systems in hypertension and effects of chronic converting-enzyme inhibition.
Topics: Adrenal Glands; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Blood Pressure; Captopril; Enalapril; Gene Expression Regulation; Heart; Hydralazine; Hypertension; Isoquinolines; Kidney; Lisinopril; Male; Quinapril; Rats; Rats, Inbred SHR; Renin; Renin-Angiotensin System; RNA, Messenger; Tetrahydroisoquinolines | 1990 |
Regional haemodynamic effects of captopril, enalaprilat and lisinopril in conscious water-replete and water-deprived Brattleboro rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Dose-Response Relationship, Drug; Enalapril; Enalaprilat; Heart Rate; Hemodynamics; Lisinopril; Male; Rats; Rats, Brattleboro; Regional Blood Flow; Water Deprivation | 1990 |
[Inhibitors of angiotensin-converting enzyme in cardiac insufficiency].
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Drug Synergism; Enalapril; Humans; Hypertension; Lisinopril | 1990 |
[The value of lysinopril in cardiac insufficiency].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Heart Failure; Humans; Lisinopril | 1990 |
Angiotensin-converting enzyme inhibitors: are there significant clinical differences?
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Heart Failure; Humans; Lisinopril; Renin-Angiotensin System | 1989 |
Changes in dyspnea-fatigue ratings as indicators of quality of life in the treatment of congestive heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Double-Blind Method; Dyspnea; Enalapril; Fatigue; Heart Failure; Humans; Lisinopril; Quality of Life; Random Allocation | 1989 |
[Angiotensin converting enzyme inhibitory activity of MK-0521 in vivo and antihypertensive effect of its single oral administration on blood pressure and effect on the renin-angiotensin system in 2-kidney Goldblatt hypertensive dogs].
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Dogs; Dose-Response Relationship, Drug; Enalapril; Female; Hypertension, Renovascular; Lisinopril; Male; Renin-Angiotensin System | 1989 |
Comparisons in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE).
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Bridged Bicyclo Compounds; Captopril; Chemotherapy, Cancer, Regional Perfusion; Dose-Response Relationship, Drug; Enalapril; Fosinopril; Heart; Hypertension; Lisinopril; Male; Organophosphorus Compounds; Proline; Ramipril; Rats; Time Factors; Tissue Distribution | 1989 |
Angiotensin converting enzyme inhibitors. Disparities in the mechanism of their antihypertensive effect.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biomechanical Phenomena; Blood Pressure; Captopril; Enalapril; Hemodynamics; Humans; Hypertension; Lisinopril; Middle Aged; Renal Circulation | 1988 |
Reduced lymphocyte stimulatory guanine nucleotide regulatory protein and beta-adrenergic receptors in congestive heart failure and reversal with angiotensin converting enzyme inhibitor therapy.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; GTP-Binding Proteins; Heart Failure; Heart Ventricles; Humans; Lisinopril; Lymphocytes; Male; Middle Aged; Myocardium; Receptors, Adrenergic, beta; Reference Values | 1988 |
Onset of action of captopril, enalapril, enalaprilic acid and lisinopril in normal man.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Enalapril; Heart Rate; Hemodynamics; Humans; Lisinopril; Male; Reference Values | 1987 |
[New momentum in cardiovascular therapy. Further development of ACE inhibitors: from captopril to lisinopril].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiovascular Diseases; Enalapril; Humans; Lisinopril | 1988 |
Inhibition of rabbit lung angiotensin-converting enzyme by N alpha-[(S)-1-carboxy-3-phenylpropyl]L-alanyl-L-proline and N alpha-[(S)-1-carboxy-3-phenylpropyl]L-lysyl-L-proline.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Dialysis; Dipeptides; Edetic Acid; Enalaprilat; Hydrogen-Ion Concentration; Kinetics; Lisinopril; Lung; Mathematics; Rabbits; Zinc | 1985 |
Enalapril maleate and a lysine analogue (MK-521) in normal volunteers; relationship between plasma drug levels and the renin angiotensin system.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Captopril; Dipeptides; Enalapril; Humans; Lisinopril; Male; Renin-Angiotensin System | 1982 |
[Acute renal insufficiency following inhibition of the angiotensin conversion enzyme by various agents].
Topics: Acute Kidney Injury; Angiotensin-Converting Enzyme Inhibitors; Captopril; Dipeptides; Female; Humans; Hypertension; Lisinopril; Middle Aged; Proline | 1984 |
Angiotensin converting enzyme inhibitors and the otolaryngologist.
Topics: Angioedema; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cough; Dose-Response Relationship, Drug; Enalapril; Humans; Hypertension; Isoquinolines; Kidney Diseases; Lisinopril; Otolaryngology; Quinapril; Tetrahydroisoquinolines | 1995 |
ISIS-4. GISSI-3 Investigators.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Double-Blind Method; Humans; Lisinopril; Multicenter Studies as Topic; Myocardial Infarction; Randomized Controlled Trials as Topic; Survival Rate | 1995 |
Bronchospasm and cough as adverse reactions to the ACE inhibitors captopril, enalapril and lisinopril. A controlled retrospective cohort study.
Topics: Aged; Bronchial Spasm; Captopril; Chi-Square Distribution; Cohort Studies; Computer Simulation; Cough; Enalapril; Female; Humans; Hypolipidemic Agents; Lisinopril; Male; Middle Aged; Prevalence; Retrospective Studies; Sex Factors; Surveys and Questionnaires | 1995 |
An intravascular ultrasound study of the influence of angiotensin-converting enzyme inhibitors and calcium entry blockers on the development of cardiac allograft vasculopathy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Captopril; Coronary Disease; Diltiazem; Enalapril; Female; Heart Transplantation; Humans; Hyperplasia; Lisinopril; Male; Middle Aged; Nifedipine; Transplantation, Homologous; Tunica Intima; Ultrasonography, Interventional; Verapamil | 1995 |
[Life-threatening angioedema as a side effect of angiotensin-converting-enzyme (ACE) inhibitors].
Topics: Aged; Aged, 80 and over; Airway Obstruction; Angioedema; Angiotensin-Converting Enzyme Inhibitors; Captopril; Emergencies; Humans; Lisinopril; Male; Middle Aged | 1995 |
Evidence for stimulation of neutrophil degranulation by selected angiotensin converting enzyme inhibitors in vitro.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cell Degranulation; Enalaprilat; Female; Humans; In Vitro Techniques; Lisinopril; Male; Middle Aged; Muramidase; Neutrophils; Peroxidase; Ramipril; Spectrophotometry; Zymosan | 1994 |
The scavenging of oxygen free radicals by angiotensin converting enzyme inhibitors: the importance of the sulfhydryl group in the chemical structure of the compounds.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalaprilat; In Vitro Techniques; Lisinopril; Reactive Oxygen Species; Sulfhydryl Compounds | 1994 |
ACE inhibitors and cough.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Cough; Enalapril; Female; Humans; Hypertension; Indoles; Lisinopril; Male; Middle Aged; Perindopril; Retrospective Studies | 1994 |
Stability and in vitro absorption of captopril, enalapril and lisinopril across the rat intestine.
Topics: Animals; Biological Transport, Active; Captopril; Drug Stability; Enalapril; In Vitro Techniques; Intestinal Absorption; Intestinal Mucosa; Kinetics; Lisinopril; Rats; Rats, Wistar; Skin | 1994 |
Effects of lisinopril and captopril on calcium in rat heart.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Calcium; Captopril; Cells, Cultured; Female; Lisinopril; Male; Myocardial Reperfusion Injury; Myocardium; Rats; Rats, Wistar; Sodium-Potassium-Exchanging ATPase; Ventricular Fibrillation | 1993 |
Angiotensin converting enzyme inhibitors as oxygen free radical scavengers.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Catalase; Chlorides; Deoxyribose; Dimethyl Sulfoxide; Edetic Acid; Enalaprilat; Ferric Compounds; Free Radical Scavengers; Hydroxyl Radical; Hypoxanthine; Hypoxanthines; Lisinopril; Luminescent Measurements; Superoxide Dismutase; Xanthine Oxidase | 1993 |
Decision analysis applied to the selection of angiotensin-converting enzyme inhibitors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Decision Support Techniques; Drug Utilization; Enalapril; Humans; Lisinopril | 1993 |
Dyspnoea, asthma, and bronchospasm in relation to treatment with angiotensin converting enzyme inhibitors.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Asthma; Bronchial Spasm; Captopril; Cough; Dyspnea; Enalapril; Female; Humans; Lisinopril; Male; Middle Aged; Ramipril | 1994 |
Captopril inhibits the 72 kDa and 92 kDa matrix metalloproteinases.
Topics: Animals; Captopril; Cells, Cultured; Chelating Agents; Dose-Response Relationship, Drug; Drug Combinations; Glomerular Mesangium; Lisinopril; Male; Metalloendopeptidases; Methods; Molecular Weight; Rats; Rats, Sprague-Dawley; Zinc | 1993 |
Drug-induced, life-threatening angioedema revisited.
Topics: Adult; Aged; Aged, 80 and over; Airway Obstruction; Angioedema; Angiotensin-Converting Enzyme Inhibitors; Captopril; Dexamethasone; Dipeptides; Diphenhydramine; Enalapril; Epinephrine; Female; Humans; Injections, Intravenous; Laryngeal Edema; Lisinopril; Male; Middle Aged; Mouth Diseases; Pharyngeal Diseases; Prognosis | 1993 |
Oxidant stress and glomerular prostanoid production: influence of angiotensin converting enzyme inhibition.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Dinoprostone; Dipeptides; Epoprostenol; Hydrogen Peroxide; Kidney Glomerulus; Lisinopril; Prostaglandins; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Thromboxane A2 | 1993 |
ACE inhibitor first dose effect.
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Dipeptides; Heart Failure; Humans; Hypotension; Indoles; Lisinopril; Middle Aged; Perindopril | 1993 |
Measurement of angiotensin I converting enzyme inhibition in the heart.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Captopril; Cricetinae; Dipeptides; Enalaprilat; Humans; Isoquinolines; Lisinopril; Male; Mesocricetus; Papillary Muscles; Tetrahydroisoquinolines | 1993 |
Angiotensin-converting enzyme inhibitors and psoriasis.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Dipeptides; Enalapril; Female; Humans; Lisinopril; Male; Middle Aged; Psoriasis; Time Factors | 1993 |
Purification and characterisation of swine serum proteinase which hydrolyses epidermal inhibitory pentapeptide.
Topics: Amino Acid Sequence; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Carboxypeptidases; Enzyme Inhibitors; Glycoproteins; Growth Inhibitors; Kinetics; Lisinopril; Molecular Sequence Data; Oligopeptides; Peptidyl-Dipeptidase A; Pyrrolidonecarboxylic Acid; Substrate Specificity; Swine | 1996 |
Cocaine-stimulated endothelin-1 release is decreased by angiotensin-converting enzyme inhibitors in cultured endothelial cells.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cattle; Cells, Cultured; Cocaine; Dose-Response Relationship, Drug; Endothelins; Endothelium, Vascular; Humans; L-Lactate Dehydrogenase; Lisinopril; Pulmonary Artery; Stimulation, Chemical; Umbilical Veins | 1996 |
[Angiotensin-converting enzyme inhibitors and anesthesia].
Topics: Aged; Anesthesia, General; Anesthetics, General; Angiotensin-Converting Enzyme Inhibitors; Captopril; Fatal Outcome; Female; Humans; Hypotension; Lisinopril; Male; Middle Aged; Preanesthetic Medication | 1996 |
ACE inhibitors unmask incoordinate diastolic wall motion in restrictive left ventricular disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Echocardiography; Enalapril; Female; Heart Failure; Humans; Lisinopril; Male; Middle Aged; Signal Processing, Computer-Assisted; Ventricular Dysfunction, Left | 1996 |
Enalapril and captopril enhance antioxidant defenses in mouse tissues.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Brain; Captopril; Enalapril; Female; Kidney; Lisinopril; Luminescent Measurements; Mice; Mice, Inbred Strains; Muscles; Myocardium; Oxidoreductases; Peroxides; tert-Butylhydroperoxide; Thiobarbituric Acid Reactive Substances; Tissue Distribution | 1997 |
[Angioedema of the mucous membranes of the upper aerodigestive tract after administration of ACE inhibitors].
Topics: Airway Obstruction; Angioedema; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Deglutition Disorders; Enalapril; Humans; Hypertension; Lisinopril; Male; Middle Aged | 1997 |
Angiotensin-converting enzyme inhibitors potentiate preconditioning through bradykinin B2 receptor activation in human heart.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Bradykinin; Captopril; Female; Heart; Heart Atria; Humans; In Vitro Techniques; Ischemic Preconditioning, Myocardial; Lisinopril; Male; Middle Aged; Receptors, Bradykinin | 1997 |
Free radical scavenging properties of alacepril metabolites and lisinopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Dose-Response Relationship, Drug; Electron Spin Resonance Spectroscopy; Free Radical Scavengers; Lisinopril; Nitric Oxide; Superoxides | 1997 |
Angiotensin-converting enzyme and neutral endopeptidase modulate smokeless tobacco-induced increase in macromolecular efflux from the oral mucosa in vivo.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Capillary Permeability; Captopril; Cricetinae; Dextrans; Enzyme Inhibitors; Fluorescein-5-isothiocyanate; Glycopeptides; Lisinopril; Male; Mesocricetus; Microcirculation; Mouth Mucosa; Neprilysin; Peptidyl-Dipeptidase A; Plants, Toxic; Protease Inhibitors; Thiorphan; Tobacco, Smokeless | 1997 |
Captopril inhibits pp60(c-src) tyrosine phosphorylation in cultured human mesangial cells.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Captopril; Cell Division; Cells, Cultured; Glomerular Mesangium; Humans; Lisinopril; Phosphorylation; Proto-Oncogene Proteins pp60(c-src); Vitamin E | 1997 |
Inhibitory action of the peptide AcSDKP on the proliferative state of hematopoietic stem cells in the presence of captopril but not lisinopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cell Cycle; Drug Interactions; Growth Inhibitors; Hematopoietic Stem Cells; Humans; Lisinopril; Mice; Oligopeptides; S Phase | 1997 |
Sheep testicular and epididymal angiotensin converting enzyme: inhibitions by captopril, lisinopril and enalapril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Enalapril; Enzyme Activation; Epididymis; Kinetics; Lisinopril; Male; Peptidyl-Dipeptidase A; Sheep; Testis | 1997 |
Different modulation of steroidogenesis and prostaglandin production in frog ovary in vitro by ACE and ANG II.
Topics: Androgens; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Dinoprost; Dinoprostone; Estradiol; Female; Gonadal Steroid Hormones; Kidney; Lisinopril; Lung; Ovary; Peptidyl-Dipeptidase A; Progesterone; Prostaglandins; Rabbits; Rana catesbeiana; Rana esculenta | 1997 |
Changes in collagen phenotypes during progression and regression of cardiac hypertrophy.
Topics: Aging; Angiotensin-Converting Enzyme Inhibitors; Animals; Blotting, Northern; Captopril; Cardiomegaly; Collagen; Heart Failure; Hydroxyproline; Lisinopril; Male; Myocardium; Rats; Rats, Inbred SHR; Rats, Inbred WKY; RNA | 1997 |
Effect of angiotensin converting enzyme inhibitors on ischaemia-reperfusion-induced renal injury in rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Female; Kidney; Lipid Peroxidation; Lisinopril; Male; Rats; Reperfusion Injury | 1998 |
Effects of sulphydryl- and non-sulphydryl-containing ACE inhibitors on left ventricular relaxation in the isolated guinea pig heart.
Topics: Acetylcysteine; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Bradykinin Receptor Antagonists; Captopril; Diastole; Female; Free Radical Scavengers; Guinea Pigs; Heart Ventricles; Hemoglobins; Isoquinolines; Lisinopril; Male; Muscle Relaxation; Nitric Oxide; Receptor, Bradykinin B2; Simethicone; Stroke Volume; Sulfhydryl Compounds; Superoxide Dismutase; Systole; Tetrahydroisoquinolines; Ventricular Dysfunction, Left | 1997 |
Inhibition of angiotensin converting enzyme from sheep tissues by captopril, lisinopril and enalapril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Enalapril; In Vitro Techniques; Kidney; Kinetics; Lisinopril; Lung; Oligopeptides; Peptidyl-Dipeptidase A; Sheep | 1997 |
Plasma ACE inhibition by five different ACE inhibitors.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Captopril; Dogs; Enalapril; Lisinopril; Peptidyl-Dipeptidase A; Ramipril | 1998 |
Captopril and lisinopril suppress production of interleukin-12 by human peripheral blood mononuclear cells.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cells, Cultured; Humans; Interferon-gamma; Interleukin-1; Interleukin-12; Leukocytes, Mononuclear; Lipopolysaccharides; Lisinopril; Lymphocyte Activation; Mitogens; Peptidyl-Dipeptidase A; Phytohemagglutinins; Staphylococcus aureus; T-Lymphocytes | 1998 |
[Hospital intensive monitoring of adverse reactions of ACE inhibitors].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Cardiotonic Agents; Data Collection; Drug Monitoring; Enalapril; Hospitals; Humans; Hypertension; Italy; Lisinopril; Renin-Angiotensin System; Risk Assessment | 1998 |
The effects of preoperative therapy with angiotensin-converting enzyme inhibitors on clinical outcome after cardiovascular surgery.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiopulmonary Bypass; Cardiovascular Diseases; Cardiovascular Surgical Procedures; Case-Control Studies; Electrocardiography; Enalapril; Female; Follow-Up Studies; Hospital Mortality; Humans; Incidence; Intra-Aortic Balloon Pumping; Lisinopril; Male; Middle Aged; Multiple Organ Failure; Postoperative Complications; Preoperative Care; Retrospective Studies; Treatment Outcome; Ventricular Dysfunction, Left | 1998 |
Presence and comparison of angiotensin converting enzyme in commercial cell culture sera.
Topics: Angiotensin II; Animals; Blood Proteins; Bradykinin; Captopril; Cattle; Culture Media; Electrophoresis, Polyacrylamide Gel; Endopeptidases; Horses; Humans; Inhibitory Concentration 50; Kinetics; Lisinopril; Oligopeptides; Peptidyl-Dipeptidase A; Silver Staining | 1999 |
Competitive inhibition of glycylsarcosine transport by enalapril in rabbit renal brush border membrane vesicles: interaction of ACE inhibitors with high-affinity H+/peptide symporter.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Binding, Competitive; Captopril; Carrier Proteins; Cell Membrane; Dipeptides; Dose-Response Relationship, Drug; Enalapril; Fosinopril; Isoquinolines; Kidney; Kinetics; Lipid Metabolism; Lipids; Lisinopril; Male; Microvilli; Peptide Transporter 1; Quinapril; Rabbits; Ramipril; Symporters; Tetrahydroisoquinolines | 1999 |
How often are angiotensin II and aldosterone concentrations raised during chronic ACE inhibitor treatment in cardiac failure?
Topics: Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Captopril; Enalapril; Female; Fosinopril; Heart Failure; Humans; Indoles; Lisinopril; Male; Peptidyl-Dipeptidase A; Perindopril; Treatment Failure | 1999 |
A mosquito (Anopheles stephensi) angiotensin I-converting enzyme (ACE) is induced by a blood meal and accumulates in the developing ovary.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Anopheles; Blood; Captopril; Eating; Female; Lisinopril; Male; Molecular Weight; Ovary; Peptidyl-Dipeptidase A | 1999 |
Inhibitor analysis of angiotensin I-converting and kinin-degrading activities of bovine lung and testicular angiotensin-converting enzyme.
Topics: Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cattle; Dipeptides; Enalapril; Kinetics; Kinins; Lisinopril; Lung; Male; Peptidyl-Dipeptidase A; Structure-Activity Relationship; Substrate Specificity; Testis | 1999 |
Mechanism of captopril toxicity to a human mammary ductal carcinoma cell line in the presence of copper.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Captopril; Carcinoma, Ductal, Breast; Copper; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; Humans; Hydrogen Peroxide; Lisinopril; Penicillamine; Tumor Cells, Cultured | 1999 |
Effects of angiotensin-converting enzyme (ACE) inhibitors on oxygen radical production and generation by murine lung alveolar macrophages.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Bronchoalveolar Lavage Fluid; Captopril; Dose-Response Relationship, Drug; Guinea Pigs; Lisinopril; Luminescent Measurements; Macrophages, Alveolar; Rats; Rats, Inbred F344; Reactive Oxygen Species; Tetradecanoylphorbol Acetate | 1999 |
Age-related progressive renal fibrosis in rats and its prevention with ACE inhibitors and taurine.
Topics: Age Factors; Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Captopril; Extracellular Matrix Proteins; Fibrosis; Kidney Cortex; Kidney Diseases; Lisinopril; Male; Rats; Rats, Inbred F344; RNA, Messenger; Taurine; Transforming Growth Factor beta | 2000 |
ACE inhibitor dosage at the time of listing predicts survival.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Female; Heart Failure; Heart Transplantation; Hemodynamics; Humans; Lisinopril; Male; Middle Aged; Prognosis; Ramipril; Survival Analysis | 2000 |
Inhibitory effects of angiotensin-converting enzyme (ACE) inhibitors on oxygen radicals produced by bronchoalveolar lavage cells in young and aged guinea pigs.
Topics: Aging; Angiotensin-Converting Enzyme Inhibitors; Animals; Bronchoalveolar Lavage Fluid; Captopril; Dose-Response Relationship, Drug; Guinea Pigs; Lisinopril; Macrophages, Alveolar; Male; Reactive Oxygen Species | 2000 |
Effect of protease inhibitors on angiotensin-converting enzyme activity in human T-lymphocytes.
Topics: Adult; Aminopeptidases; Angiotensin-Converting Enzyme Inhibitors; Calpain; Captopril; Cathepsins; Chymotrypsin; Cysteine Proteinase Inhibitors; Humans; Leucine; Leupeptins; Lisinopril; Lymphocyte Activation; Male; Oligopeptides; Peptidyl-Dipeptidase A; Protease Inhibitors; T-Lymphocytes | 2000 |
Comparison of zofenopril and lisinopril to study the role of the sulfhydryl-group in improvement of endothelial dysfunction with ACE-inhibitors in experimental heart failure.
Topics: Acetylcholine; Acetylcysteine; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Blood Pressure; Body Weight; Calcimycin; Captopril; Endothelium, Vascular; Heart Diseases; In Vitro Techniques; Lisinopril; Male; Myocardial Infarction; Nitrates; Nitrites; Nitroglycerin; omega-N-Methylarginine; Rats; Rats, Wistar; Sodium Nitrite; Sulfhydryl Compounds; Vasodilation; Vasodilator Agents | 2000 |
Angiotensin I-converting enzyme transition state stabilization by HIS1089: evidence for a catalytic mechanism distinct from other gluzincin metalloproteinases.
Topics: Amino Acid Sequence; Angiotensin-Converting Enzyme Inhibitors; Animals; Asparagine; Binding Sites; Captopril; Catalysis; COS Cells; Histidine; Humans; Lisinopril; Metalloendopeptidases; Molecular Sequence Data; Peptidyl-Dipeptidase A; Protein Binding; Protein Structure, Tertiary; Recombinant Proteins; Sequence Homology, Amino Acid; Transfection | 2001 |
Angiotensin-converting enzyme inhibitor dosages in elderly patients with heart failure.
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Female; Heart Failure; Humans; Lisinopril; Male; Retrospective Studies; Treatment Outcome; Ventricular Dysfunction, Left | 2001 |
Angiotensin converting enzyme inhibitors and cough--a north Indian study.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cough; Enalapril; Female; Follow-Up Studies; Humans; Hypertension; Incidence; India; Indomethacin; Lisinopril; Male; Middle Aged; Prospective Studies; Ramipril; Risk Assessment | 1998 |
Suppression of experimental abdominal aortic aneurysms in the rat by treatment with angiotensin-converting enzyme inhibitors.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Blood Pressure; Captopril; Enalapril; Lisinopril; Losartan; Male; Pancreatic Elastase; Rats; Rats, Wistar | 2001 |
Characterization of bovine atrial angiotensin-converting enzyme.
Topics: Animals; Captopril; Catalysis; Cattle; Chromatography, Affinity; Chromatography, Gel; Chromatography, Ion Exchange; Heart Atria; Hydrogen-Ion Concentration; Hydrolysis; Kinetics; Lisinopril; Lung; Oligopeptides; Peptidyl-Dipeptidase A; Substrate Specificity | 2001 |
Characterization of angiotensin-converting enzyme in canine testis.
Topics: Acrosome; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Chromatography, Affinity; Dogs; Edetic Acid; Ethylmaleimide; Kinetics; Lisinopril; Male; Molecular Weight; Peptidyl-Dipeptidase A; Spermatids; Spermatozoa; Testis; Zinc | 2001 |
Usefulness of patch tests for diagnosing selective allergy to captopril.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cross Reactions; Drug Hypersensitivity; Enalapril; Female; Glyburide; Humans; Lisinopril; Patch Tests; Skin Tests | 2001 |
Hypotension after first-dose ACE inhibitor administration in heart failure--should doctors stop worrying?
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Enalapril; Heart Failure; Humans; Hypotension; Lisinopril; Perindopril | 2001 |
Role of liquid membrane phenomenon in biological actions of ACE inhibitors, captopril and lisinopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cellulose; Lisinopril; Membrane Fluidity; Membranes, Artificial; Permeability; Surface Properties | 2001 |
Captopril and quinapril reduce reactive oxygen species.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cells, Cultured; Dose-Response Relationship, Drug; Enalaprilat; Fluoresceins; Fluorescent Dyes; Humans; Isoquinolines; Leukocytes, Mononuclear; Lisinopril; NADPH Oxidases; Quinapril; Reactive Oxygen Species; Tetradecanoylphorbol Acetate; Tetrahydroisoquinolines | 2002 |
Crystal structure of Drosophila angiotensin I-converting enzyme bound to captopril and lisinopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Crystallography, X-Ray; Drosophila; Lisinopril; Models, Molecular; Peptidyl-Dipeptidase A; Protein Conformation; Substrate Specificity | 2003 |
ACE inhibitors reduce fecundity in the mosquito, Anopheles stephensi.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Anopheles; Captopril; Culicidae; Dose-Response Relationship, Drug; Female; Fertility; Lisinopril; Oviposition; Peptidyl-Dipeptidase A; Reproduction | 2003 |
Myogenic constriction is increased in mesenteric resistance arteries from rats with chronic heart failure: instantaneous counteraction by acute AT1 receptor blockade.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Bridged Bicyclo Compounds, Heterocyclic; Captopril; Chronic Disease; Coronary Vessels; Disease Models, Animal; Endothelium-Dependent Relaxing Factors; Endothelium, Vascular; Fatty Acids, Unsaturated; Heart; Heart Failure; Hydrazines; Imidazoles; Indomethacin; Lisinopril; Losartan; Male; Mesenteric Arteries; Nitric Oxide; omega-N-Methylarginine; Pyridines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Superoxide Dismutase; Sympathetic Nervous System; Tetrazoles; Tetrodotoxin; Vascular Resistance | 2003 |
Evidence for the negative cooperativity of the two active sites within bovine somatic angiotensin-converting enzyme.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Binding Sites; Captopril; Cattle; Hydrolysis; Kinetics; Lisinopril; Oligopeptides; Peptides; Peptidyl-Dipeptidase A; Protein Structure, Tertiary; Structure-Activity Relationship; Substrate Specificity; Titrimetry | 2003 |
Captopril inhibits glucose accumulation in retinal cells in diabetes.
Topics: Adrenergic beta-Antagonists; Aldehyde Reductase; Angiotensin-Converting Enzyme Inhibitors; Animals; Atenolol; Blood Glucose; Blotting, Western; Captopril; Cattle; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Endothelium, Vascular; Glucose; Glucose Transporter Type 1; Lisinopril; Male; Monosaccharide Transport Proteins; Rats; Rats, Sprague-Dawley; Retina; Retinal Vessels | 2003 |
The problem of underdosing of angiotensin-converting enzyme inhibitors is markedly overrated: results from a study of patients discharged from hospital after an acute myocardial infarction.
Topics: Acute Disease; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Utilization; Enalapril; Evaluation Studies as Topic; Female; Hospitalization; Humans; Lisinopril; Male; Myocardial Infarction; Patient Discharge; Pharmacoepidemiology; Ramipril; Randomized Controlled Trials as Topic | 2004 |
Purified angiotensin converting enzyme from Rana esculenta ovary influences ovarian steroidogenesis in vitro.
Topics: Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Captopril; Female; Hydrogen-Ion Concentration; Lisinopril; Oligopeptides; Ovary; Rana esculenta; Renin; Sodium Chloride; Steroids; Temperature | 2003 |
[Prophylactic use of angiotensin-converting enzyme inhibitors in indomethacin-induced ulcer and erosion lesions of the stomach].
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Captopril; Disease Models, Animal; Enalapril; Gastric Mucosa; Indomethacin; Lisinopril; Male; Rats; Stomach Ulcer; Treatment Outcome | 2004 |
A calorimetric study of the binding of lisinopril, enalaprilat and captopril to angiotensin-converting enzyme.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Calorimetry; Captopril; Enalaprilat; Lisinopril; Lung; Peptidyl-Dipeptidase A; Swine; Thermodynamics | 2004 |
The effect of angiotensin-converting enzyme inhibitors on experimental colitis in rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Colitis; Collagen; Colon; Disease Models, Animal; Enzyme Inhibitors; Female; Glutathione; Lisinopril; Male; Malondialdehyde; Organ Size; Peroxidase; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Time Factors; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha | 2005 |
Kinetic probes for inter-domain co-operation in human somatic angiotensin-converting enzyme.
Topics: Angiotensin-Converting Enzyme Inhibitors; Binding Sites; Captopril; Humans; Kinetics; Lisinopril; Peptidyl-Dipeptidase A; Protein Binding; Protein Structure, Tertiary; Substrate Specificity | 2005 |
Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: putting guidelines into practice.
Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzopyrans; Biphenyl Compounds; Bisoprolol; Captopril; Carbazoles; Carvedilol; Drug Therapy, Combination; Enalapril; Ethanolamines; Evidence-Based Medicine; Guideline Adherence; Heart Failure; Humans; Indoles; Lisinopril; Metoprolol; Mineralocorticoid Receptor Antagonists; Nebivolol; Practice Guidelines as Topic; Propanolamines; Ramipril; Spironolactone; Stroke Volume; Tetrazoles; Valine; Valsartan | 2005 |
Validated ligand mapping of ACE active site.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Catalytic Domain; Computer Simulation; Crystallography, X-Ray; Enalapril; Humans; Ligands; Lisinopril; Models, Molecular; Molecular Conformation; Molecular Structure; Peptidyl-Dipeptidase A; Ramipril; Zinc | 2005 |
Hydrochlorothiazide increases plasma or tissue angiotensin-converting enzyme-inhibitor drug levels in rats with myocardial infarction: differential effects on lisinopril and zofenopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Creatinine; Drug Therapy, Combination; Heart Ventricles; Hydrochlorothiazide; Hypertrophy, Left Ventricular; Kidney; Kidney Function Tests; Lisinopril; Male; Myocardial Infarction; Peptidyl-Dipeptidase A; Prodrugs; Rats; Rats, Sprague-Dawley; Ventricular Function | 2005 |
Captopril inhibits the oxidative modification of apolipoprotein B-100 caused by myeloperoxydase in a comparative in vitro assay of angiotensin converting enzyme inhibitors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Apolipoprotein B-100; Apolipoproteins B; Atherosclerosis; Captopril; Enalapril; Fosinopril; Humans; Hydrogen Peroxide; Hypochlorous Acid; Lipoproteins, LDL; Lisinopril; Oxidation-Reduction; Peroxidase; Ramipril; Recombinant Proteins | 2006 |
Porcine germinal angiotensin I-converting enzyme: isolation, characterization and molecular cloning.
Topics: Amino Acid Sequence; Animals; Base Sequence; Captopril; Cloning, Molecular; DNA, Complementary; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Enzyme Activation; Enzyme Stability; Hydrogen-Ion Concentration; Immunohistochemistry; Kinetics; Lisinopril; Male; Molecular Sequence Data; Molecular Weight; Peptidyl-Dipeptidase A; Semen; Sequence Analysis, DNA; Sequence Homology, Amino Acid; Substrate Specificity; Sus scrofa; Temperature; Testis | 2007 |
Inhibition of matrix metalloproteinase activity by ACE inhibitors prevents left ventricular remodeling in a rat model of heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Arteriovenous Shunt, Surgical; Captopril; Compliance; Disease Models, Animal; Heart Failure; Hypertrophy, Left Ventricular; Lisinopril; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase Inhibitors; Myocardial Contraction; Myocardium; Quinapril; Rats; Rats, Sprague-Dawley; Tetrahydroisoquinolines; Time Factors; Venae Cavae; Ventricular Function, Left; Ventricular Pressure; Ventricular Remodeling | 2007 |
CX3CR1 receptor is up-regulated in monocytes of coronary artery diseased patients: impact of pre-inflammatory stimuli and renin-angiotensin system modulators.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Captopril; Case-Control Studies; Cell Line; Coronary Artery Disease; CX3C Chemokine Receptor 1; Female; Humans; In Vitro Techniques; Inflammation Mediators; Interferon-gamma; Jurkat Cells; Lisinopril; Losartan; Male; Middle Aged; Monocytes; Receptors, Chemokine; Recombinant Proteins; Renin-Angiotensin System; Tumor Necrosis Factor-alpha; Up-Regulation | 2007 |
Captopril and lisinopril decrease acetaldehyde effects upon the prothrombin time.
Topics: Acetaldehyde; Antihypertensive Agents; Captopril; Humans; In Vitro Techniques; Lisinopril; Prothrombin Time | 2008 |
Anticoagulant activity of captopril.
Topics: Anticoagulants; Antihypertensive Agents; Captopril; Disulfides; Dose-Response Relationship, Drug; Fibrinogen; Humans; Lisinopril; Partial Thromboplastin Time; Polylysine; Prothrombin Time; Sulfhydryl Compounds; Thrombin; Thrombin Time | 2008 |
Angiotensin-converting enzyme-like activity in crab gills and its putative role in degradation of crustacean hyperglycemic hormone.
Topics: Amino Acids; Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Arthropod Proteins; Brachyura; Captopril; Cations, Divalent; Chromatography, High Pressure Liquid; Edetic Acid; Gills; Half-Life; Invertebrate Hormones; Iodine Radioisotopes; Kinetics; Lisinopril; Male; Metals; Nerve Tissue Proteins; Oligopeptides; Peptidyl-Dipeptidase A; Tissue Distribution | 2008 |
RAS inhibitors decrease apoptosis of acinar cells and increase elimination of pancreatic stellate cells after in the course of experimental chronic pancreatitis induced by dibutyltin dichloride.
Topics: Actins; Aldosterone; Animals; Apoptosis; Captopril; Cell Proliferation; Enalapril; Immunohistochemistry; Lisinopril; Losartan; Male; Organotin Compounds; Pancreas; Pancreatitis, Chronic; Rats; Rats, Inbred Lew; Renin-Angiotensin System | 2008 |
Multifactorial etiology of Kaposi' sarcoma: a hypothesis.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; HIV Infections; Humans; Lisinopril; Risk Factors; Sarcoma, Kaposi | 2008 |
Carboxypeptidase activity common to viridans group streptococci cleaves angiotensin I to angiotensin II: an activity homologous to angiotensin-converting enzyme (ACE).
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Base Sequence; Captopril; Carboxypeptidases; Chromatography, High Pressure Liquid; Electrophoresis, Polyacrylamide Gel; Enalapril; Endocarditis, Bacterial; Fibrinogen; Humans; Lisinopril; Molecular Sequence Data; Peptidyl-Dipeptidase A; Sequence Analysis, DNA; Streptococcal Infections; Streptococcus gordonii | 2011 |
Decreased risk of radiation pneumonitis with incidental concurrent use of angiotensin-converting enzyme inhibitors and thoracic radiation therapy.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Carcinoma, Non-Small-Cell Lung; Humans; Incidence; Lisinopril; Lung; Lung Neoplasms; Male; Middle Aged; Radiation Pneumonitis; Retrospective Studies; Small Cell Lung Carcinoma; Tumor Burden | 2012 |
Prediction of clinically relevant safety signals of nephrotoxicity through plasma metabolite profiling.
Topics: Animals; Captopril; Cyclosporine; Doxorubicin; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Kidney Diseases; Lisinopril; Male; Metabolome; Metabolomics; Phenytoin; Rats; Rats, Wistar | 2013 |
Surface plasmon resonance analysis of the binding mechanism of pharmacological and peptidic inhibitors to human somatic angiotensin I-converting enzyme.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; CHO Cells; Cricetinae; Cricetulus; Enzymes, Immobilized; Humans; Lisinopril; Oligopeptides; Peptidyl-Dipeptidase A; Protein Binding; Protein Interaction Mapping; Surface Plasmon Resonance | 2013 |
Mitigation of experimental radiation nephropathy by renin-equivalent doses of angiotensin converting enzyme inhibitors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Biomarkers; Bone Marrow Transplantation; Calibration; Captopril; Enalapril; Fosinopril; Kidney; Kidney Diseases; Lisinopril; Male; Radiation Injuries; Ramipril; Rats; Renin; Renin-Angiotensin System; Whole-Body Irradiation | 2014 |
Captopril and lisinopril only inhibit matrix metalloproteinase-2 (MMP-2) activity at millimolar concentrations.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Dose-Response Relationship, Drug; Fluorometry; Humans; Hydrogen-Ion Concentration; Lisinopril; Matrix Metalloproteinase 2; Recombinant Proteins | 2014 |
Application of quantitative NMR for purity determination of standard ACE inhibitors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Calibration; Captopril; Carbon; Deuterium Oxide; Enalapril; Enzyme Inhibitors; Hydrogen-Ion Concentration; Imidazolidines; Lisinopril; Magnetic Resonance Spectroscopy; Maleates; Methanol; Quinapril; Reference Standards; Solvents; Stereoisomerism; Tetrahydroisoquinolines | 2015 |
Angiotensin converting enzyme immobilized on magnetic beads as a tool for ligand fishing.
Topics: Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Animals; Captopril; Cattle; Chromatography, Liquid; Enalapril; Enzymes, Immobilized; Inhibitory Concentration 50; Iron; Kinetics; Ligands; Lisinopril; Lung; Magnetite Nanoparticles; Peptidyl-Dipeptidase A; Reproducibility of Results; Surface Properties; Tandem Mass Spectrometry; Trypsin | 2017 |
Simultaneous determination of ACE inhibitors and dexibuprofen in active pharmaceutical ingredient, formulations and human serum by RP-HPLC.
Topics: Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Captopril; Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Humans; Ibuprofen; Limit of Detection; Lisinopril; Tablets | 2017 |
Self-Assembly of Angiotensin-Converting Enzyme Inhibitors Captopril and Lisinopril and Their Crystal Structures.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Lisinopril | 2021 |
Enhanced purification protocol for the angiotensin-converting enzyme from bovine systems and investigation of the in vitro effect of some active substances.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cattle; Chromatography, Affinity; Fosinopril; Hydrogen-Ion Concentration; Kinetics; Lisinopril; Lung; Peptidyl-Dipeptidase A; Protein Stability; Temperature; Triamterene | 2021 |
Enhancement of EPC migration by high-dose lisinopril is superior compared to captopril and ramipril.
Topics: Captopril; Endothelial Progenitor Cells; Humans; Leukocytes, Mononuclear; Lisinopril; Ramipril | 2021 |